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The impact of intestinal helminth infection on the clinical presentation and immune response
during active tuberculosis (TB) infection is not well characterized. Our aim was to investi-
gate whether asymptomatic intestinal helminth infection alters the clinical signs and symp-
toms as well as the cell mediated immune responses in patients with active TB.
Methodology
Consecutive, newly diagnosed TB patients and healthy community controls (CCs) were
recruited in North-west Ethiopia. TB-score, body mass index and stool samples were ana-
lyzed. Cells from HIV-negative TB patients (HIV-/TB) and from CCs were analyzed for regu-
latory T-cells (Tregs) and cytokine responses using flow cytometry and ELISPOT,
respectively.
Results
A significantly higher ratio of helminth co-infection was observed in TB patients without HIV
(Helm+/HIV-/TB) compared to HIV negative CCs, (40% (121/306) versus 28% (85/306),
p = 0.003). Helm+/HIV-/TB patients showed significantly increased IL-5 secreting cells
compared to Helm-/HIV-/TB (37 SFU (IQR:13–103) versus 2 SFU (1–50); p = 0.02, n = 30).
Likewise, levels of absolute Tregs (9.4 (3.2–16.7) cells/μl versus 2.4 (1.1–4.0) cells/μl; p =
0.041) and IL-10 secreting cells (65 SFU (7–196) versus 1 SFU (0–31); p = 0.014) were
significantly higher in Helm+/HIV-/TB patients compared to Helm-/HIV-/TB patients. In a
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multivariate analysis, a lower rate of sputum smear positivity for acid fast bacilli, lower body
temperature, and eosinophilia were independently associated with helminth infection in TB
patients.
Conclusions
Asymptomatic helminth infection is associated with increased regulatory T-cell and Th2-
type responses and a lower rate of sputum smear positivity. Further studies are warranted
to investigate the clinical and immunological impact of helminth infection in TB patients.
Author Summary
The effects of helminth infection on chronic infectious diseases such as tuberculosis (TB)
merit further characterization. There is limited data regarding the impact of helminth co-
infection on clinical and immunological outcomes of TB from clinical field studies in high
endemic areas. We tried to address some of these issues in a randomized clinical trial in
order to investigate the impact of albendazole treatment on helminth co-infected TB
patients. In the present study we focused on the clinical and immunological effects of hel-
minth infection on TB. We found that concomitant asymptomatic helminth infection pro-
foundly affects the immune phenotype of TB patients with a strong leaning towards Th2
types of immune response such as increased regulatory T cells as well as IL-5 and IL-10
secreting cells. Furthermore, helminth co-infection was associated with a significantly
lower ratio of sputum smear positivity which correlated to the egg load in helminth posi-
tive TB patients. Whether the effect of helminth infection may have an impact on the diag-
nosis and treatment of active TB remains to be further investigated.
Introduction
The high prevalence of chronic infectious diseases such as HIV, tuberculosis (TB) and hel-
minth infection has a significant impact on public health in Africa [1]. The majority of TB
cases and TB related deaths occur in resource poor countries [2] where TB is the most common
life-threatening opportunistic infection in patients with HIV/AIDS [3–4]. In addition, hel-
minths are estimated to infect one third of the world population [5–7] mostly affecting poor,
tropical and subtropical areas [8–9].
Symptomatic helminth infection has been shown to be associated with malnutrition mea-
sured by low body mass index (BMI) and mid upper arm circumference (MUAC) in children
[10]. Helminth infections are widely present in populations where TB and HIV are highly
endemic. In high endemic areas of TB such as Ethiopia, helminth co-infection in TB patients
has been shown to range between 30–71% [4,11–12].
Protection against TB is strongly associated with enhanced T-helper cell type 1 (Th1)
immune responses [13] while susceptibility to the disease is associated with reduced Th1 type
responses and enhanced Th2 and regulatory T-cell responses (Tregs) [14]. Evidence is accumu-
lating that chronic helminth infection may affect host immunity in TB [15–17]. The current
vaccine against TB, Bacille Calmette Guerin (BCG), has poor efficacy against adult pulmonary
TB in sub-Saharan Africa and one reason might be that helminth infection modulates the
immune response by increasing Treg activity and thereby attenuating the effects of the vaccine
[18].
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In a cohort of TB patients in Ethiopia, we previously showed that asymptomatic helminth
infection is associated with eosinophilia and elevated IgE levels, supporting the fact that hel-
minth infection affects host immunity during TB [12]. We also recently reported that albenda-
zole treatment of TB patients with helminth infection compared to placebo leads to a reduced
level of eosinophilia and IL-10 [19]. In the present study our aim was to compare helminth-
positive and helminth-negative TB patients in order to investigate whether asymptomatic hel-
minth infection affects clinical signs and symptoms as well as cell mediated immune responses
in patients with active TB.
Materials and Methods
Study participants
Consecutive newly diagnosed pulmonary TB patients (15–60 years old) were recruited at the
Directly Observed Treatment Short-course (DOTS) clinics located at Gondar University Hos-
pital, Gondar Health Centre and Debark Hospital, Ethiopia. We enrolled smear positive and
smear negative pulmonary TB patients at the DOTS clinics after a decision to treat the patients
for TB was made by clinicians working in the respective health facilities following clinical, labo-
ratory and chest x-ray examinations according to the WHO based criteria. A patient was con-
sidered smear positive when at least one sputum sample was positive for acid fast bacilli (AFB)
in the presence of clinical symptoms for active TB. Smear negative TB was defined as clinical
symptoms suggestive for TB with three negative sputum smears, radiographic abnormalities
consistent with pulmonary TB and a lack of response to a one week course of broad spectrum
antibiotic therapy. Exclusion criteria were pregnancy and infectious diseases other than TB and
HIV. For purposes of comparison, apparently healthy community controls (CCs) were
recruited from the same community. All the CCs were recruited from the blood bank of the
Gondar University Hospital. In addition to the routine clinical screening at the blood bank,
only blood donors with a TB-score of less than 3 [20] and a normal chest x-ray finding were
included as healthy community controls. The data on a subset of TB patients (Helm+/TB) was
partly described in a randomized clinical study on deworming presented elsewhere [19] and
Helm-/TB patients included in the present study were investigated in an identical way.
Socio-demographic and clinical characteristics
A structured questionnaire was used to collect socio-demographic and clinical information.
The clinical TB-score (from 0 to 13 points) was assessed by measuring signs and symptoms
suggestive for TB (cough, haemoptysis, chest pain, dyspnoea, night sweating, tachycardia, tem-
perature>37°C, MUAC and BMI) as previously described [20–21].
HIV-screening and treatment
Testing for HIV was done at the voluntary counseling and testing clinic and at the DOTS clinic
according to the hospital routine with HIV rapid test kits of KHB (HIV 1/2 rapid test strip,
China), Stat-Pak (HIV 1/2, Chembio Diagnostics Inc., USA) and Unigold (Trinity Biotech,
USA). HIV-positive patients were referred to the HIV clinics for further assessment and free
antiretroviral treatment according to Ethiopian HIV/AIDS treatment guideline [22]. All
patients were provided Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI) based regi-
men where the standard regimen at the time of the study was Efavirenz with Zidovudine and
Lamivudine.
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Measurement of CD4+ T-cells and eosinophil counts
The CD4+T-cells count was analyzed using FACSCount (BD, San Jose, California, USA) avail-
able at Gondar and Debark Hospital laboratories. The absolute eosinophil count of peripheral
blood was computed in cells/mm3 from the value of total and differential white blood cell
counts obtained using Cell Dyn 1800 (Abbot, USA).
Stool microscopy and acid fast staining of sputum samples
Stool microscopy was done to examine intestinal parasites in samples collected on three conse-
cutive days using direct microscopy and Kato-Katz technique as previously described [23]. The
classification of patients into helminth-positive or-negative was based on the results of all three
samples together from each patient. One in 10 slides were randomly selected and examined by
a second microscopist for quality control. Acid fast bacilli (AFB) load was measured and
described using the World Health Organization protocol as: negative (0 AFB/100 oil fields),
scanty (1–9 AFB/100 oil fields), + (10–99 AFB/100 oil fields), ++ (1–10 AFB/oil field) and +++
(> 10 AFB/oil field) [24].
Analysis of regulatory T-cells by flow cytometry
Peripheral blood mononuclear cells, (PBMCs) were isolated by the density gradient separation
method using lymphoprep solution as described previously [19,25] and stored at -80°C in FCS
containing 10% DMSO. Trypan-blue (Sigma-Aldrich, USA) exclusion was used for determina-
tion of cell viability and only samples with viability above 75% were used for experimental
assays. PBMCs were stained with CD4-FITC (BD Biosciences), CD25-Percp Cy5.5 (BD Biosci-
ences), and CD127-Alexa 647 (BD Biosciences), followed by fixation/permeabilization using
cytofix/cytoperm solution (BD Biosciences) and intracellular staining with monoclonal anti-
bodies (mAbs) against FOXP3- phycoeryhtrin (PE) (BD Biosciences). Tregs were defined as
the population of cells being CD4+/CD25hi/CD127low/FOXP3. The total level of FOXP3+
CD25hi CD127lo CD4+ T cells were determined by multiplying the percentage of these cells in
the lymphocyte gate by the number of circulating CD4+ T-cells per μl blood.
ELISPOT analysis of IL-5, IFN-γ and IL-10
Cells (PBMCs) were plated (250,000/well) on PVDF plates (Mabtech, Sweden) coated with a
capture mAb specific for human IFN-γ (1-D1K), IL-5 (TRFK5) and IL-10 (9D7) at a concen-
tration of 15μg/ml in PBS. Cells were incubated in a humidified incubator at 37°C in 5% CO2
for 24 h with purified protein derivate (PPD, Statens Serum Institute, Denmark) antigens in
duplicate using unstimulated and anti-CD3-stimulated cells as negative and positive controls,
respectively.
Ethics statement
Written informed consent was obtained from all study participants and in case of children
under 18, from the respective guardians. In addition, children from 15–18 gave assent. The
study was approved by the Ethical Review Board of the University of Gondar, Ethiopia and
from the Ethical Review Board, Linköping University, Sweden.
Statistical analysis
Data are presented as median and interquartile ranges. Comparison between groups was done
by chi-square test or Fisher´s exact test for discrete variables and Mann-Whitney U test for
continuous variables using STATISTICA software (Tulsa, USA). Multiple regression analysis
Impact of Helminth Co-Infection in Tuberculosis
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was performed on variables with a P value< 0.1 in the univariate analysis including age, sex
and HIV in the model. A P< 0.05 was regarded as statistically significant.
Results
Socio-demographic and clinical characteristics
A total of 424 newly and consecutively diagnosed pulmonary TB patients and 306 CCs were
included in this study. The overall HIV co-infection rate among TB patients (HIV+/TB) was
28% (118/424), whereas all the CCs were HIV-negative. Seventy percent of the HIV+/TB
patients were on anti-retroviral treatment (ART). As the immunological and clinical impact of
helminth infection was the main research question and these factors are heavily influenced by
HIV, the immunological data were analyzed separately for HIV-/TB patients and the multivari-
ate analysis included HIV in the model. The median age for Helm+/HIV-/TB and Helm-/
HIV-/TB patients was 26 (20–35) and 26 (20–37) years, respectively, p = 0.80 (Table 1),with no
significant difference in age between CCs with or without helminth infection.
Stool microscopy
The prevalence of helminth infection was significantly higher among HIV-/TB patients com-
pared to CCs (40% (121/306) versus 28% (85/306), p = 0.003). The burden of helminth infec-
tion was lower at a borderline significant level in HIV+/TB patients compared to HIV-/TB
patients (30% (35/118) versus 40% (121/306), p = 0.06 in the univariate analysis). Ascaris lum-
bricoides was the prevailing parasite detected among Helm+/HIV-/TB patients (53%, 63/120)
and the CCs (52%, 44/85). No significant differences in the burden of helminth infection were
observed among HIV-/TB patients enrolled at the University of Gondar Hospital (42%, 30/71),
Gondar Health Center (38%, 53/140) and Debark Hospital (40%, 38/95).
The clinical impact of helminth infection in patients with active TB
In a multivariate analysis, helminth co-infection was associated with a lower rate of sputum
AFB smear positivity and the association was stronger with increasing smear grade (adjusted
OR for a smear grade2: 0.43 (95% CI: 0.23–0.79), p = 0.007; Table 2). Furthermore, the
mean egg load was significantly lower in patients with a smear grade2 (83±247 eggs,
n = 155) compared to patients with a smear grade of 1 (253±900 eggs, n = 122) or sputum
smear negative patients (229±607 eggs, n = 103; p = 0.028 Kruskal-Wallis and R = -0.138;
Table 1. Socio-demographic characteristics of patients with active tuberculosis infection.
HIV-/TB patients
Helminth-positive n Helminth-negative n p*
Age, median 26 (20–35) 26 (20–37) 0.801
Sex:
M 69% 121 59% 185 0.054
F 31% 121 41% 185 0.052
Literate (%) 57% 121 60% 184 0.301
Smoking (%) 15% 120 7% 185 <0.001
Monthly income
No income 57% 121 65% 183 0.094
*p-value between Helm+/HIV-/TB versus Helm-/HIV-/TB
doi:10.1371/journal.pntd.0003994.t001
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p = 0,007 for correlation by the Spearman test). No significant difference was observed between
Helm+/TB and Helm-/TB patients for other clinical parameters such as the TB-score (7.5±2.6
versus 7.8±2.5, p = 0.3), BMI or MUAC. A lower body temperature (<37°C), walking bare foot
as well as smoking were each independently associated with helminth infection (Table 2).
Helminth infection is associated with increased regulatory T-cell
frequency and Th2-type response in TB patients
In the multivariate analysis, eosinophilia (>300 cells/mm3) was independently associated with
helminth infection in TB patients (adjusted OR: 1.98 (95% CI: 1.2–3.2), p = 0.007) (Table 2).
We analyzed IFN-γ, IL-5 and IL-10 secreting cells from a subset of 30 HIV negative TB patients
and 56 CCs with and without helminth infection. Significantly increased median levels of IL-5
and IL-10 secreting cells measured in the ELISPOT-assay by spot forming units (SFU) were
observed in unstimulated cells from Helm+/HIV-/TB patients compared with Helm-/HIV-/TB
patients (IL-5: 37 SFU(IQR:13–103) versus 2 SFU(1–50); p = 0.02) and (IL-10: 65 SFU(7–196)
versus 1 SFU (0–31); p = 0.014), respectively (Fig 1A).Similarly, a significant increment in IL-5
(147 SFU (52–236) versus 16 SFU (2–59); p = 0.0017) as well as IL-10 secreting cells (119 SFU
(19–347) versus 32 (1–118); p = 0.046) were observed following PPD stimulation among Helm
+/HIV-/TB patients (Fig 1B). There was no difference in the levels of IFN-γ secreting cells
between the two groups for unstimulated cells (57 SFU (29–118) versus 67 SFU (1–118);
p = 0.45) but a significant difference in PPD-stimulated cells (244 SFU (126–291 vs 45 SFU (9–
196), p = 0.027). The absolute levels of Tregs were also increased in Helm+/HIV-/TB compared
to Helm-/HIV-/TB patients (9.4 (3.2–16.7) cells/μl versus 2.4 (1.1–4.0) cells/μl; p = 0.041). In
the healthy controls (CCs), no significant differences were observed in IFN-γ, IL-5, IL-10
Table 2. Multivariate analysis of the impact of helminth co-infection in patients with active tuberculosis. Laboratory parameters (eosinophilia and
sputum smear grade), clinical variables from the TB-score as well as socio-demographic variables and risk factors were analysed in a univariate model
where variables with p<0.1 were entered into the multivariate model shown in Table 2. Age, gender and HIV were included in the final model. F = female,
M = male.
Helminths Univariate Multivariate
N n % OR (95% conf. int.) p OR (95% conf. int.) p
Age <28 206 80 38.8 1.00 1.00
28 218 76 34.9 0.84 (0.57–1.25) 0.397 0.67 (0.40–1.11) 0.117
Gender F 174 60 34.5 1.00 1.00
M 250 96 38.4 1.18 (0.79–1.77) 0.411 1.25 (0.74–2.11) 0.117
HIV No 306 121 39.5 1.00 1.00
Yes 118 35 29.7 0.64 (0.41–1.02) 0.060 0.79 (0.45–1.39) 0.413
Walking bare foot No 307 118 38.4 1.00 1.00
Yes 118 30 25.4 1.68 (1.11–2.54) 0.013 1.84 (1.11–3.06) 0.019
Smoking No 374 129 34.5 1.00 1.00
Yes 48 25 52.1 2.06 (1.12–3.79) 0.019 3.20 (1.42–7.19) 0.005
Sputum smear grade 0 (negative) 114 53 46.5 1.00 1.00
1 131 47 35.9 0.73 (0.57–0.94) 0.65 (0.48–0.89)
2 168 53 31.5 0.54 (0.33–0.88) 0.013 0.43 (0.23–0.79) 0.007
Eosinophilia (>300 cells/μl) No 161 58 36.0 1.00 1.00
Yes 156 82 52.6 1.97 (1.25–3.09) 0.003 1.98 (1.22–3.22) 0.006
Body temperature > 37°C No 141 60 42.6 1.00 1.00
Yes 283 96 33.9 0.69 (0.46–1.05) 0.084 0.62 (0.37–1.04) 0.067
doi:10.1371/journal.pntd.0003994.t002
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secreting cells nor in absolute levels of Tregs among Helm+/CCs versus Helm-/CCs, respec-
tively (S1A and S1B Fig).
Discussion
The main finding of this study is that during active TB, helminth infection is associated with
increased regulatory T-cell and Th2-type responses. Additionally, helminth infection is signifi-
cantly correlated to a reduced rate of sputum smear positivity with a correlation between an
increasing sputum smear grade and a decreasing egg load.
We found increased level of IL-10 associated with helminth infection in TB patients as com-
pared to helminth negative TB patients. This is in line with a recent report where we observed
that IL-10 was significantly reduced following albendazole treatment of helminth-positive TB
patients compared to placebo [19]. In HIV-patients without TB, a previous clinical trial also
showed that albendazole treatment induced a decline in serum IL-10 levels [26]. Altogether,
this indicates a role for IL-10 in the helminth induced immunomodulation. Anti-helminthic
treatment in TB patients may therefore decrease worm burden, leading to impairment of the
IL-10 production and improved cellular immunity to TB which could have potential clinical
benefits.
Recent results indicate that increased activity of Tregs and regulatory cytokines such as IL-
10 may contribute to pathogen persistence by modulating the host immune response in infec-
tious diseases such as TB [27]. In animal models, it has been shown that Tregs are associated
with helminth infection [28]. Regulatory T-cells are common in the gut which is the usual site
of infection for helminths [29]. The Th2-dominance in many infections such as TB is main-
tained by IL-10- and TGF-βmediated suppression of competing Th1 and Th17-cell popula-
tions [18]. This has been shown in a mouse filariasis model using L. sigmodontis where the
chronic phase of infection is marked by T-cell anergy, loss of proliferative responses to parasite
antigen, reductions in effector cytokine levels, and elevated expression of inhibitory cytokines
and cells such as IL-10 and Tregs [30]. In human filarial and ascaris infections, the presence of
helminths correlate with both increased production of IL-10 [31], and generalized T-cell hypo-
responsiveness [32]. In addition, the observed epidemiological association of increased preva-
lence of helminth infection with a lower ratio of allergic manifestations and autoimmune
inflammatory conditions in humans is linked to an attenuated immune response by Tregs and
IL-10 [33–35]. Altogether, these experimental and clinical data suggest an immunosuppressive
role for increased regulatory T-cell and IL-10 activity [26] which is in line with our present
findings.
Regarding the clinical impact of helminth infection in TB patients, we found a lower sputum
smear rate and lower body temperature among Helm+/HIV-/TB patients. Interestingly, hel-
minth negative TB patients showed an association to increasing sputum smear grade and
among helminth positive TB patients, there was a correlation between higher sputum smear
grades and lower helminth egg loads. One possible explanation might be that the higher level
of Tregs and increased levels of the regulatory cytokine, IL-10, could suppress the inflamma-
tory and Th1-associated immune responses leading to reduced cavity formation and conse-
quently a reduced sputum smear load. A similar pattern has been reported in HIV/TB co-
infection where HIV was associated to a reduction in CD4+ counts together with a reduced
Fig 1. A-B. Distribution of IFN-gamma, IL-5 and IL-10 in HIV-/tuberculosis (TB) patients with and
without helminth (Helm) infection analyzed by ELISPOT. A. Unstimulated cells.B. PPD-stimulated cells.
Vertical bars lines represent the median level of spot forming units (SFU) per 250 000 peripheral blood
mononuclear cells (PBMCs). *p<0.05 and **p<0.01.
doi:10.1371/journal.pntd.0003994.g001
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sputum smear positivity rate compared to HIV-/TB patients [36–38]. In HIV co-infected TB
patients, it is known that the inflammatory infiltrate is less well organized with reduced cavity
formation along with increasing immunosuppression. Thus, the immunological impact of HIV
and helminth co-infection in TB may result in reduced sensitivity of the sputum smear exami-
nation, a diagnostic method still widely used in high endemic areas.
An association between increased prevalence of intestinal helminth infection and pulmo-
nary TB has been repeatedly reported from the present study area [4,11–12]. Consistent with
our previous finding in another cohort of TB patients from the same area [12], we verified
again that close to 40% of TB patients are asymptomatically infected with intestinal parasites.
The evaluation of helminth infection was based on the examination of three consecutive
stool samples, by both direct and the Kato-Katz method. As limitation of this study, this
method could miss low-grade helminth infection. Moreover, the immunological impact of hel-
minths may be species dependent but apart from Ascaris lumbricoides, this correlation could
not be evaluated within the present study due to a limited samples size. Furthermore, the TB
diagnosis was based on the clinician’s intention to treat a patient with anti-TB drugs based on
clinical, sputum smear, and chest x-ray examinations according to the WHO based criteria for
smear positive and smear negative TB and not by sputum culture confirmation. The level of
non-tuberculosis mycobacteria is very low and was not detected in a previous study of smear
positive TB patients from the area [39] which is consistent with other reports from Ethiopia
showing that NTMs are found at a frequency less than 2% among smear positive TB patients
[40].
In summary, we show that helminth infection is significantly associated with increased reg-
ulatory T-cell activity, an increased Th2 type response, as well as reduced rate of sputum smear
positivity in patients with active TB in a high endemic area for both TB and helminth infection.
These results may have implications for diagnosis and immunotherapy in patients from areas
where both infections are endemic.
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